Atrial Fibrillation

Primary care management of atrial fibrillation (AF)

Date: Part 1: 8th June 2021 & Part 2: 29th June 2021

Cost: Free

Virtual Workshops 20:00 - 21:30

These promotional educational meetings have been developed by Soar Beyond and the BMS/Pfizer Alliance and is fully funded by the BMS/Pfizer Alliance. This is intended for UK Healthcare Professionals only. Treatment options will be discussed at this meeting. Eliquis (apixaban) prescribing information can be found here.

Adverse events should be reported. Reporting forms and information can be found here, or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Bristol-Myers Squibb via [email protected] or 08007311736 (UK)

The i2i Network is delighted to be bringing you these two-part virtual workshops designed specifically to equip practice pharmacists to manage patients with atrial fibrillation (AF), using case studies and practical examples from our expert speakers. This programme will focus on the potential role of the GP clinical pharmacist to ‘Protect’ and ‘Perfect’ AF management. The virtual workshops are, however, open to any health care professional.

Speakers

Nathan Hutchinson-Jones

Nathan Hutchinson-Jones is the Lead Pharmacist for Thrombosis and Anticoagulation at the Royal United Hospital (RUH), Bath where he has helped optimise anticoagulation services, including the setting up of a pharmacist led cancer associated thrombosis clinic. He has previously worked as a rotational clinical pharmacist in secondary care and as a GP medicines optimisation pharmacist for Bristol Clinical Commissioning Group (CCG).

Read Bio
Nigel Rowell

Nigel was a Practice Based Commissioning Chairman, Vice-chairman of the Tees Health Authority and a CCG board member. He was involved nationally as a Clinical Advisor to NHS Improvement and a Northern region Clinical Champion in AF, promoting AF detection and early adoption of DOACs.

Nigel was later invited onto the writing team for the European Heart Rhythm Association Practical Guide to DOACs which has just received publication for the 2021 edition. He remains active within the national GPSI Cardiology movement, and educational programmes around AF and anticoagulation in general. Nigel recently retired from NHS clinical practice but resuscitated his registration to help as medical lead for the local Covid vaccination service.

 

 

Read Bio

Agenda

The agenda for part 1 will equip you to:

  • Understand the background to AF (Atrial Fibrillation) and the principle of ‘Protect’ when managing AF
  • Review the core treatment and management options for AF including how to ‘Protect’ patients
  • Understand the impact of the latest AF clinical guidance on practice
  • Know how to assess bleeding risk

The agenda for part 2 will equip you to:

  • Understand how to ‘Perfect’ anticoagulant treatment
  • Understand the impact of the latest AF clinical guidance on practice
  • Be aware of the impact of Covid-19 and switching patients from vitamin K antagonists (VKAs) to direct oral anticoagulants (DOACs)
  • Feel confident in supporting patients with adherence to DOACs

Supported by

sponsor

These promotional educational meetings have been developed by Soar Beyond and the BMS/Pfizer Alliance and is fully funded by the BMS/Pfizer Alliance. This is intended for UK Healthcare Professionals only. Treatment options will be discussed at this meeting. Eliquis (apixaban) prescribing information can be found here.

Adverse events should be reported. Reporting forms and information can be found here, or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Bristol-Myers Squibb via [email protected] or 08007311736 (UK).

Job bag : CV-GB-2100097

Date of Preparation May 2021

Hide

Health Care Professionals Attend An Event

Book onto an event as a healthcare professional
  • All communication will be received through this email.
  • This field is for validation purposes and should be left unchanged.